Medicine and Dentistry
Antiretroviral Therapy
100%
Human Immunodeficiency Virus
96%
Patient
47%
Human Immunodeficiency Virus Infection
38%
Therapeutic Procedure
32%
Person
32%
Serositis
31%
Mortality
28%
Death
27%
Cardiovascular Disease
26%
Interleukin 6
25%
Biological Marker
23%
Cell Count
20%
Disease
20%
Adult
19%
Drug
19%
Chemotherapeutic Agent
19%
Inpatient
17%
Predictor
17%
Hazard Ratio
17%
D-Dimer
17%
C Reactive Protein
16%
Cells
15%
Coagulation
15%
Morbidity
14%
Malignant Neoplasm
14%
Follow up
14%
Arm
13%
Combination Therapy
13%
Plasma
13%
Randomized Controlled Trial
11%
Virus RNA
11%
Prevalence
11%
Development
11%
Chronic Kidney Disease
11%
Ebolavirus
11%
Association
11%
Treatment Interruption
11%
Clinical Trial
10%
Age
10%
Liver Fibrosis
9%
Nephropathy
8%
Hepatitis B Virus
8%
Restylane
8%
RNA
8%
T-Helper Cell
7%
Placebo
7%
Amaurosis
7%
Thrombin
7%
ZMapp
7%
Nursing and Health Professions
Antiretroviral Therapy
33%
Diseases
14%
Mortality
14%
Inflammation
12%
Death
12%
Cardiovascular Disease
11%
CD4 Lymphocyte Count
11%
Hazard Ratio
11%
Interleukin 6
10%
Confidence Interval
10%
Human Immunodeficiency Virus Infection
9%
Morbidity
8%
C Reactive Protein
8%
Immune Deficiency
8%
Biological Marker
7%
Combination Therapy
7%
D Dimer
6%
Drug
5%
Patient
5%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
35%
Drug
15%
Mortality
13%
Death
12%
Cardiovascular Disease
11%
Inflammation
11%
Diseases
8%
Ebola Virus Disease
7%
Hepatitis B Virus
7%
Morbidity
6%
Interleukin 6
5%